Oral Gallium Maltolate is an active formulation of gallium, a drug previously approved by the FDA in intravenous form (gallium nitrate for injection). The intravenous form, however, required continuous IV administration for 5-7 days. Oral GaM, on the other hand, has a different anti-tumor mechanism in the way it is absorbed in the body. It mimics the role of iron that is needed for tumor cells to grow. Ultimately, the tumor cells consume gallium, not iron, which interferes with iron-dependent cancer cell functions, growth, and proliferation. Thus far GaM has been extremely well tolerated by patients and it can be taken in the comfort of home. We helped get an expanded access program for this treatment started, but could only cover part of the costs. We need your help to cover more of the costs so more patients can get access to this promising treatment! 100% of donations made on this page will go toward this expanded access program - while these funds are needed. After the program is completed, any remaining funds will be used for other research projects! Please donate by using the form on the right . You can also send a check made out to "Musella Foundation" with "Gallium Maltolate Project" in the memo and mail to: 1100 Peninsula Blvd, Hewlett, NY 11557. Call us at 888-295-4740 if you have any problems or questions! Encourage family and friends to donate! Donations are tax deductible to the full extent of the law. Gallium Maltolate Project Fund Status
Fund Usage:
|
Donations to the Gallium Maltolate Project FundIf you do donate, please consider checking to see if your employer has a corporate match policy: If you prefer donating with a check, print out this page and mail it with a check made out to "Musella Foundation" to: Musella Foundation 1100 Peninsula Blvd Hewlett, NY 11557 888-295-4740 Phone 516-295-2870 Fax |